Rhelion Life Sciences Corp. (CSE:RHEL)
0.0200
+0.0050 (33.33%)
At close: Nov 20, 2026
Rhelion Life Sciences Earnings Call Transcripts
Fiscal Year 2025
-
Revenue grew 4% to $4.9M with a 24% reduction in adjusted EBITDA loss, driven by cost discipline and a focus on functional mushroom products. Strong cash reserves, strategic asset sales, and a new Bitcoin treasury strategy position the company for controlled growth amid sector volatility.